Conghua Xie

51PUBLICATIONS
82CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Apr 28, 2026
Identification of a Novel Radiosensitivity-Related Signature and Validation of GPX8 in Regulating the Radiosensitivity of Glioma.

|Feb 16, 2026
The role of thoracic radiotherapy in the setting of immunotherapy in polymetastatic esophageal squamous cell carcinoma: a multi-center cohort study.

Qi Liu, Junqiang Chen, Wenbin Shen

|Nov 26, 2025
TMEM131-Mediated Soluble TRAIL Triggered Type II Alveolar Epithelial Cell Senescence in Radiation-Induced Lung Injury.

Linzhi Han, Chunsheng Wang, Xiuli Guo

|Jun 20, 2025
Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy.

Xiangling Xiao, Jie Shi, Chuan He

|May 16, 2025
USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity.

Panpan Dai, Yishuang Sun, Zhengrong Huang

|Nov 20, 2024
Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study.

Yu Lin, Wenbin Shen, Jinjun Ye

Pageof 9

Frequent Collaborators

16 joint publications

Yan Gong

4 joint publications

Jinfang Zhang

3 joint publications

Gordon J Freeman

3 joint publications

Xiangling Xiao